{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:04:42Z","timestamp":1793293482243,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the 2024 Cultivation Program of the National Natural Science Foundation of China","award":["gyfynsfc[2024]-53"],"award-info":[{"award-number":["gyfynsfc[2024]-53"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43495-8","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T03:13:47Z","timestamp":1776568427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The mechanism of fibronectin 1 promoting papillary thyroid cancer progression by regulating anoikis resistance"],"prefix":"10.1038","volume":"16","author":[{"given":"Shengcan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"issue":"10387","key":"43495_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen, D. W., Lang, B. H. H., McLeod, D. S. A., Newbold, K. & Haymart, M. R. Papillary thyroid cancer. Lancet (London England). 401 (10387), 1531\u20131544. https:\/\/doi.org\/10.1016\/S0140-6736(23)00020-X (2023). https:\/\/pubmed.ncbi.nlm.nih.gov\/37023783\/","journal-title":"Lancet (London England)"},{"issue":"8","key":"43495_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.medcli.2024.12.005","volume":"164","author":"JL Reverter","year":"2025","unstructured":"Reverter, J. L. Papillary thyroid cancer. C\u00e1ncer de tiroides. Med. Clin. 164 (8), 421\u2013428. https:\/\/doi.org\/10.1016\/j.medcli.2024.12.005 (2025).","journal-title":"Med. Clin."},{"issue":"20","key":"43495_CR3","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.3390\/jcm13206119https","volume":"13","author":"M Boudina","year":"2024","unstructured":"Boudina, M., Zisimopoulou, E., Xirou, P. & Chrisoulidou, A. Aggressive Types of Malignant Thyroid Neoplasms. J. Clin. Med. 13 (20), 6119. 10.3390\/jcm13206119 (2024).","journal-title":"J. Clin. Med."},{"issue":"2","key":"43495_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41556-025-01630-z","volume":"27","author":"DJV David","year":"2025","unstructured":"David, D. J. V. Mesoderm FN1 shaping the heart. Nat. Cell Biol. 27 (2), 175. https:\/\/doi.org\/10.1038\/s41556-025-01630-z (2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/39948268\/","journal-title":"Nat. Cell Biol."},{"issue":"7","key":"43495_CR24","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/biology12070954","volume":"12","author":"ANDREWSMR DAVIS-LUNN M,GOULT BT","year":"2023","unstructured":"DAVIS-LUNN M,GOULT BT, A. N. D. R. E. W. S. M. R. Clutching at Guidance Cues: The Integrin\u2013FAK Axis Steers Axon Outgrowth. Biology 12 (7), 954. (2023). https:\/\/doi.org\/10.3390\/biology12070954","journal-title":"Biology"},{"issue":"3","key":"43495_CR5","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.apsb.2022.09.020","volume":"13","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. Roles of Focal Adhesion Proteins in Skeleton and Diseases. Acta Pharm. Sinica B. 13 (3), 998\u20131013. https:\/\/doi.org\/10.1016\/j.apsb.2022.09.020 (2023).","journal-title":"Acta Pharm. Sinica B"},{"issue":"2","key":"43495_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"TADDEI","year":"2012","unstructured":"TADDEI et al. Anoikis: an emerging hallmark in health and diseases[J]. J. Pathol. 226 (2), 380\u2013393. https:\/\/doi.org\/10.1002\/path.3000 (2012).","journal-title":"J. Pathol."},{"key":"43495_CR7","doi-asserted-by":"publisher","first-page":"950927","DOI":"10.3389\/fcell.2022.950927","volume":"10","author":"PAHLAVANI H A","year":"2022","unstructured":"PAHLAVANI H A. Exercise-induced signaling pathways to counteracting cardiac apoptotic processes[J]. Front. Cell. Dev. Biol. 10, 950927. https:\/\/doi.org\/10.3389\/fcell.2022.950927 (2022).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"6","key":"43495_CR8","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/cas.70041","volume":"116","author":"X Meng","year":"2025","unstructured":"Meng, X. et al. FN1 Immunoregulation in Glioblastoma: Insights From Neutrophil-Centric Studies. Cancer Sci. 116 (6), 1758\u20131772. https:\/\/doi.org\/10.1111\/cas.70041 (2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/40052499\/","journal-title":"Cancer Sci."},{"key":"43495_CR9","doi-asserted-by":"publisher","unstructured":"Kumar, P. et al. Ajit, Big Data Analysis in Computational Biology and Bioinformatics. Methods in molecular biology (), 2719, 181\u2013197. https:\/\/doi.org\/10.1007\/978-1-0716-3461-5_11 (2024). https:\/\/pubmed.ncbi.nlm.nih.gov\/37803119\/","DOI":"10.1007\/978-1-0716-3461-5_11"},{"issue":"1","key":"43495_CR10","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1038\/s41598-024-83915-1","volume":"15","author":"BZ Ring","year":"2025","unstructured":"Ring, B. Z., Cronister, C. T., Ring, H. Z., Ross, D. T. & Seitz, R. S. Immune infiltrate populations within distinct tumor immune microenvironments predictive of immune checkpoint treatment outcome. Sci. Rep. 15 (1), 3126. https:\/\/doi.org\/10.1038\/s41598-024-83915-1 (2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/39856115\/","journal-title":"Sci. Rep."},{"key":"43495_CR11","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"43495_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"43495_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3892\/ol.2024.14643","volume":"28","author":"H Pan","year":"2024","unstructured":"Rocco D, Tortora A, Marotta V, Machado AM, Selistre-de-Ara\u00fajo HS, Vitale M. Integrin-fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma. Endocr Relat Cancer. 2025 Jun 5;32(6):e250101. https:\/\/doi.org\/10.1530\/ERC-25-0101","journal-title":"Oncol. Lett."},{"issue":"6","key":"43495_CR14","doi-asserted-by":"publisher","first-page":"e250101","DOI":"10.1530\/ERC-25-0101","volume":"32","author":"D Rocco","year":"2025","unstructured":"Pan, H., Luo, Z., Lin, F., Zhang, J., Xiong, T., Hong, Y., Sun, B., & Yang, Y. (2024). FN1, a reliable prognostic biomarker for papillary thyroid cancer, is associated with tumor immunity and an unfavorable prognosis. Oncology letters, 28(5), 510. https:\/\/doi.org\/10.3892\/ol.2024.14643","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"43495_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2174\/0929866530666221019162943","volume":"30","author":"C Chen","year":"2023","unstructured":"Chen, C. & Shen, Z. FN1 Promotes Thyroid Carcinoma Cell Proliferation and Metastasis by Activating the NF-\u039ab Pathway. Protein Pept. Lett. 30 (1), 54\u201364. https:\/\/doi.org\/10.2174\/0929866530666221019162943 (2023). https:\/\/pubmed.ncbi.nlm.nih.gov\/36278453\/","journal-title":"Protein Pept. Lett."},{"key":"43495_CR16","doi-asserted-by":"publisher","first-page":"217873","DOI":"10.1016\/j.canlet.2025.217873","volume":"629","author":"M Han","year":"2025","unstructured":"Han, M. et al. Isocucurbitacin B inhibits gliomas through the promotion of anoikis by targeting caveolin 1. Cancer Lett. 629, 217873 (2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/40516904\/","journal-title":"Cancer Lett."},{"key":"43495_CR17","doi-asserted-by":"publisher","first-page":"101099","DOI":"10.1016\/j.drup.2024.101099","volume":"75","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Targeting anoikis resistance as a strategy for cancer therapy. Drug Resist. Updat. 75, 101099. https:\/\/doi.org\/10.1016\/j.drup.2024.101099 (2024). https:\/\/pubmed.ncbi.nlm.nih.gov\/38850692\/","journal-title":"Drug Resist. Updat"},{"key":"43495_CR18","doi-asserted-by":"publisher","first-page":"110792","DOI":"10.1016\/j.cellsig.2023.110792","volume":"109","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y. et al. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK\/ERK\/PI3K signaling. Cell. Signal. 109, 110792. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110792 (2023). https:\/\/pubmed.ncbi.nlm.nih.gov\/37406787\/","journal-title":"Cell. Signal."},{"issue":"10","key":"43495_CR19","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.3390\/cancers15102720","volume":"15","author":"H Zheng","year":"2023","unstructured":"Zheng, H. et al. PLA2R1 Inhibits Differentiated Thyroid Cancer Proliferation and Migration via the FN1-Mediated ITGB1\/FAK Axis. Cancers (Basel). 15 (10), 2720. https:\/\/doi.org\/10.3390\/cancers15102720 (2023). https:\/\/pubmed.ncbi.nlm.nih.gov\/37345058\/","journal-title":"Cancers (Basel)"},{"issue":"10","key":"43495_CR20","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.3390\/cancers15102720","volume":"15","author":"H Zheng","year":"2023","unstructured":"Liu M, Chen P, Wei B, Tan HL, Zhao YX, Ai L, Li N, Jiang YK, Lin J, Li SJ, Chang S. FN1 shapes the behavior of papillary thyroid carcinoma through alternative splicing of EDB region. Sci Rep. 2025 Jan 2;15(1):327. https:\/\/doi.org\/10.1038\/s41598-024-83369-5","journal-title":"Cancers"},{"issue":"2","key":"43495_CR21","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s12020-024-04068-9","volume":"87","author":"S Kilicarslan","year":"2025","unstructured":"Kilicarslan, S. & Hiz-Cicekliyurt, M. M. Identification of potential biomarkers of papillary thyroid carcinoma. Endocrine 87 (2), 758\u2013771. https:\/\/doi.org\/10.1007\/s12020-024-04068-9 (2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/39400774\/","journal-title":"Endocrine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43495-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43495-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43495-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:22:20Z","timestamp":1781648540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43495-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43495"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43495-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,19]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in strict accordance with the principles of the Declaration of Helsinki and approved by the Ethics Review Committee of the Affiliated Hospital of Guizhou Medical University (Ethics Approval No.: GMU2024-452). All participants were patients aged 30\u201370 years who underwent thyroid resection at the Affiliated Hospital of Guizhou Medical University between November 2024 and August 2025, and were pathologically confirmed as PTC with no history of preoperative chemoradiotherapy, cognitive impairment, or other concomitant malignancies. Prior to tissue sampling, all participants (or their legally authorized representatives, if applicable) were provided with a detailed written explanation of the study purpose, procedures, potential risks, and the intended use of tissue samples (for experimental research on papillary thyroid cancer molecular mechanisms only, without involvement in commercial applications). Written informed consent was obtained from each participant to confirm their voluntary participation and agreement to the use of their de-identified tissue samples and clinical data (e.g., pathological stage, survival information) for this study. All tissue samples were anonymized by removing personal identifiers (e.g., name, hospital ID) immediately after collection, and stored and processed in compliance with the hospital\u2019s ethical guidelines for biological sample management to protect participant privacy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17857"}}